课题基金 / 基金详情

LACTATION INDUCED REDUCTION IN BREAST CANCER RISK

LACTATION INDUCED REDUCTION IN BREAST CANCER RISK
哺乳期降低乳腺癌风险
批准号:
2733289
负责人:
DAVID KIANG
金额:
$19.07万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1996
资助国家:
美国
项目状态:
已结题
起止时间:
1996-09-17 至 2000-06-30

项目摘要

项目成果

DAVID KIANG的其他基金

相似基金

相关文献

中文摘要
翻译
描述:生命早期的怀孕和哺乳与 降低人类乳腺癌的风险,而人类诱导的假孕 绒毛膜促性腺激素(HCG)对乳腺有保护作用 大鼠的肿瘤发生。申请人假设,通过扩大差距, 正常乳腺在哺乳期的连接细胞间通讯 上皮细胞可以有效地对少数转化或 癌前细胞。在本申请书中,申请人提议[目标1] 人绒毛膜促性腺激素增强细胞间通讯调节基因 暴露于NMU的大鼠乳腺的变化;[Aim II]增强 细胞间通讯调节MCF-10细胞的遗传改变 和逗号ID单元格。在AIM III中,他将研究转录 催乳激素或其他调节对人类Cx26基因的调节 探员们。
英文摘要
DESCRIPTION: Pregnancy and lactation early in life are associated with a reduced risk of human breast cancer, while pseudopregnancy induced by human chorionic gonadotropin (hCG) has a protective effect against mammary tumorigenesis in rats. The applicant hypothesizes that, by an enhanced gap junction intercellular communication during lactation, the normal mammary epithelial cells can effectively exert influence on a few transformed or premalignant cells. In this application the applicant proposes [Aim 1] that enhanced cell-cell communication induced by hCG modulates genetic alterations in rat mammary glands exposed to NMU; and [Aim II] that enhanced cell-cell communication modulates the genetic alterations in MCF-10 cells and comma-ID cells. In Aim III, he will investigate the transcriptional regulation of the human Cx26 gene by lactogenic hormones or other modulation agents.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development, implementation and long-term maintenance of an ISO accredited progra
Development, implementation and long-term maintenance of an ISO accredited progra
Development, implementation and long-term maintenance of an ISO accredited progra
ASTROVIRUS NONSTRUCTURAL PROTEINS
  • 批准号:
    6176446
  • 项目类别:
  • 资助金额:
    $4.09万
  • 财政年份:
    2000
  • 负责人:
    DAVID KIANG
  • 依托单位:
海外基金